Orchid and Merck & Co enter R&D collaboration for anti-infectives
This article was originally published in Scrip
Executive Summary
Orchid Chemicals and Pharmaceuticalsand Merck & Cohave entered into a R&D collaboration and licence agreement to develop novel agents for bacterial and fungal infections.